Additionally, the COSMIC database reports that 2.81% and 0.6% (498 samples) of prostate tumours have upregulated or down-regulation CSNK1A1 expression, respectively, in the TCGA dataset [50,51]. This evidence concerns the gene CSNK1A1 and prostate neoplasm.